1Turner RC, Millns H, Neil HAW, et al. Risk factors for coronary artery disease in non-dependent diabetes mellitus: United Kingdom prospectivediabetes study (UKPDS23) [J]. BMJ, 1998,316(7134) :823-828.
2Stamler J,Vaccro O,Neaton JD, et al. Diabetes,other risk factors,and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trail[ J]. Diabetes Care, 1993,16(2) :434-444.
3WHO, 1999 World Health Organization-International Society of Hypertension guideline for the management of hypertension. Guidelines Subcommittee[ J]. J Hypertens, 1999,17 (2): 151-183.
5UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes: ( UKPDS38 ) [ J ]. BMJ, 1998,317(7160) :703-713.
6The Expert Committee on the diagnosis and classification of diabetes mellitus:Report of the Expert Committee on the diagnosis and classification of diabetes mellitus [ J]. Diabetes Care, 1999,22 [ Suppl 1 ]: S5 S19.
7Aberti KGMM, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus:provisional report of a WHO consultation[J]. Diabet Med, 1998,15 (7): 539-553.
8Haffner SM. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease [J]. Endocr Rev, 1998, 19 (5): 583-592.
9Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes[J]. Diabetes, 1999,48(9): 1856-1862
10Tominaga M,Eguchi H,Manaka H, et al.Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose :the Funagata Diabetes Study [ J ]. Diabetes Care, 1999,22 (6): 920-924.
9KEMAN WN, VISCOLI CM, LNZUCCHI SE, et al. Prevalence of abnormal glucose tolerance following transient ischemic attack or ischemic stroke [ J ]. Arch Int Med,2005,165 ( 2 ) : 227 - 233.
10Gray CS, Hildreth AJ, Sandewock PA, et al. Glucose- potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK)[J]. Lancet Neurol, 2007,6 (5) : 397-406.
